Novartis AG (NVS) Sentiment
30-day SentiSense Score -1.84 · Neutral · ▲ warming · as of 2026-09-23
NVS sentiment is neutral (30-day SentiSense Score -2) and strengthening from a month ago; today's read is hotter at 31, above its 30-day average. Attention averages ~31 mentions/day (17 today).
- Sentiment (30-day)
- Neutral
- SentiSense Score (30-day avg)
- -1.84
- Today's read
- 31.17 (Bullish)
- Mentions / day (30-day avg)
- 31 (17 today)
Where the conversation is happening
- News
- Neutral · 75% of mentions
- X
- Neutral · 14% of mentions
- YouTube
- Bearish · 7% of mentions
- Bullish · 4% of mentions
Related tickers
What's driving it
- Novartis shares plunge over 10% after del‑desiran trial failure rattles biotech sector (-0.82)
- Novartis' pelacarsen misses its cardiovascular endpoint, erasing CHF4.9 billion and raising the bar for every Lp(a) rival (-0.89)
- Novartis' Pelacarsen Fails Phase 3 Trial, Royalty Pharma Anticipates Modest Return (-0.57)
Live SentiSense Score, sentiment history, and per-source breakdown for Novartis AG on SentiSense.
See how NVS's sector compares in the market sentiment heatmap